Join
Live feed
·
INSIDERFilingvia Quantisnow
MoonLake Immunotherapeutics logo

Chief Scientific Officer Reich Kristian converted options into 48,978 units of Class A ordinary shares and returned 48,978 units of Class C ordinary shares to the company, decreasing direct ownership by 77% to 35,389 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MLTX· MoonLake Immunotherapeutics
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MLTX (MoonLake Immunotherapeutics) and more on Quantisnow.

Chief Scientific Officer Reich Kristian converted options into 48,978 units of Class A ordinary shares and returned 48,978 units of Class C ordinary shares to the company, decreasing direct ownership by 77% to 35,389 units (SEC Form 4) | Quantisnow